Results 221 to 230 of about 5,486 (237)
Some of the next articles are maybe not open access.
Observations on midodrine in a case of vasodepressor neurogenic syncope
Clinical Autonomic Research, 1995A 43-year-old man presented with recurrent syncope and dizziness after he had a dual chamber pacemaker fitted for presumed sino-atrial disease. Head-up tilt produced vasodepressor neurocardiogenic syncope, despite appropriate heart rate support during pacing, and reproduced symptoms. Symptoms were not improved by disopyramide. A double-blind cross-over
Rose Anne Kenny, C. Ward
openaire +3 more sources
Establishing the Efficacy of Midodrine to Prevent Vasovagal Syncope
Annals of Internal Medicine, 2021Sheldon and colleagues reported the efficacy of midodrine in a well-powered randomized trial. The editorialist discusses the findings and predicts that the future of therapy for recurrent vasovagal...
openaire +2 more sources
Midodrine for Treatment of Vasovagal Syncope
2000Most vasovagal fainters who seek medical attention require no more than the reassurance that their physician understands the basis of their symptoms, and education regarding both the nature of the problem and techniques which may avert recurrences. However, when spells are frequent, or are associated with physical injury, or threaten to compromise ...
Keith G. Lurie +5 more
openaire +2 more sources
The Use of Midodrine in Patients With Advanced Heart Failure
Congestive Heart Failure, 2009In many patients, the treatment of heart failure (HF) cannot be optimized because of pre‐existing or treatment‐induced hypotension. Midodrine, a peripheral α1‐adrenergic agonist may allow for up‐titration of neurohormonal antagonist therapy leading to improved outcomes.
Ramzan M. Zakir +3 more
openaire +3 more sources
Hemodialysis in Hypotensive Heart Failure Using Midodrine
The American Journal of the Medical Sciences, 2009Dialysis in patients with severe congestive heart failure and low blood pressure is difficult even in a hospital setting. We retrospectively recorded the effects and usefulness of an alpha (1) agonist in an outpatient dialysis unit in 5 patients with end-stage renal disease with symptomatic heart failure and low blood pressure.
openaire +3 more sources
Efficacy of Midodrine for Neurogenic Orthostatic Hypotension
JAMA: The Journal of the American Medical Association, 1997To the Editor. —Orthostatic hypotension due to autonomic failure is an incapacitating condition for which treatment, despite various drug interventions (eg, yohimbine, metoclopramide, β-blockers, somatostatin analog) is not yet resolved. Therefore, the encouraging results of the study of Dr Low and colleagues 1 are potentially of great importance ...
openaire +2 more sources
Accelerated Approval and Possible Withdrawal of Midodrine
JAMA, 2010Rita F. Redberg, Sanket S. Dhruva
openaire +3 more sources